Summary
The Synthetic Hemo-technologIEs to Locate and Disinfect (SHIELD) program aims to develop technologies that will transform how the military manages and treats blood stream infections (BSI).
Specifically, SHIELD will develop prophylaxes that can be broadly administered to trauma victims in combat casualty care scenarios which will rapidly clear multiple bloodborne bacterial and fungal pathogens, limit morbidity and mortality, and protect the recipient for up to 7 days.